Clinical Trial Update: Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE) [Phase 1, Phase 2]

View source ↗

Summary

This clinical-trial update reports Phase 1 and Phase 2 investigations of erythropoietin in infants with hypoxic ischemic encephalopathy, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Tanta University | Conditions: Hypoxic Ischemic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED